News & Views

From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.

Read more
Show me:
Showing 800 articles
Image
News placeholder image
12.06.2020

Launch of Befriender Scheme

This week we are delighted to launch our Befriender Scheme funded by the National Lottery Fund.
Back to Top
Brand Icons/Telephone check - FontAwesome icons/tick icons/uk